68
Pharma & HealthcareBuy
Invesco India Pharma and Healthcare
Invesco · Direct–Growth · rank #4 of 19 by Smart Score
Data updated
Trailing returns
1 Year
—
3 Years
—
5 Years
—
Since launch
-5.2%
Why this score
Invesco India Pharma and Healthcare scores 68/100 — #4 of 19 Pharma & Healthcare fund (Buy). It stands out for expense ratio — beating 97% of peers on expense ratio. The main drag is its fund size (better than only 34% of peers).
Each bar shows the fund's percentile vs Pharma & Healthcare peers — a longer bar beats more of the category.
Expense ratio0.59% · 97th percentile in category
Fund size435.52 Cr · 34th percentile in category
Top holdings
1.Max Healthcare Institute Ltd9.58%
2.Sun Pharmaceutical Industries Ltd8.99%
3.Sai Life Sciences Ltd.8.63%
4.Apollo Hospitals Enterprise Ltd8.03%
5.Manipal Health Enterprises Ltd7.98%
13 disclosed equity positions · portfolio as of Sept 2026 · weights are % of total corpus.